Search Tag: vaccine development

Executive Health Management

2022 01 May

Find ASM On Social Media Read more

Executive Health Management

2020 13 Oct

Johnson & Johnson has announced temporarily pausing the COVID-19 vaccine candidate trials due to an unexplained illness in a study participant.   You might also like: Rushing COVID-19 Vaccine Development: Is It Justified?   As reported by STAT News, the company has informed external researchers through a document that a “passing...Read more

Executive Health Management

2020 28 May

The U.S. is joining the COVID-19 vaccine race with a massive testing effort planned for this year, and Russia might start vaccinations this autumn. While many warn against rushing the vaccine development, others point to ethical ways to potentially accelerate the trials.   You might also like: Where Does COVID-19 Vaccine Development...Read more

Executive Health Management

2020 20 Apr

Sir Andrew Witty, president of UnitedHealth Group and CEO of Optum and f ormer GlaxoSmithKline (GSK) chief executive , has taken a leave of absence from his current job to join the World Health Organization (WHO) in the agency’s efforts to develop a COVID-19 vaccine.   You may also like: Where Does COVID-19 Vaccine Development Stand?...Read more

Executive Health Management

2020 11 Apr

Researchers around the world are testing a wide range of COVID-19 vaccine candidates, with over a hundred vaccines in development, and almost 600 clinical trials either ongoing or completed.   You may also like : Teaming and Funding Opportunities for COVID-19 Researchers   The Coalition for Epidemic Preparedness Innovations (CEPI),...Read more